This inventor holds 1 USPTO granted patent. Top assignee: Abclon Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jong Ho Lee: Innovator in Protein Purity and Antigen Affinity
Introduction
Jong Ho Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that enhance protein purity and affinity for antigens. His work is crucial for advancements in medical diagnostics and therapeutic applications.
Latest Patents
Jong Ho Lee holds a patent for a polypeptide improved in protein purity and affinity for antigen, along with a conjugate thereof with an antibody or antigen-binding fragment, and the preparation method for the same. This innovation is pivotal in enhancing the effectiveness of antibody-based therapies and diagnostics.
Career Highlights
Currently, Jong Ho Lee is associated with Abclon Inc., a company that focuses on developing innovative biopharmaceuticals. His expertise and research have contributed to the company's mission of advancing healthcare solutions through cutting-edge technology.
Collaborations
Jong Ho Lee collaborates with Hyun Jong Lee, further enhancing the research and development efforts at Abclon Inc. Their combined expertise fosters innovation and drives the company’s projects forward.
Conclusion
Jong Ho Lee is a distinguished inventor whose work in polypeptide technology is shaping the future of medical science. His contributions are vital for the development of more effective therapeutic and diagnostic tools.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile